Feed Top Reports Pricing

⌘K

00:15:20·869d

SECFilingvia Quantisnow

SEC Form EFFECT filed by Blucora Inc.

ByQuantisnow·Wall Street's wire, on your screen.

BCOR· Blucora Inc.

Finance

Original source

This insight was delivered by Quantisnow - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BCOR (Blucora Inc.) and more on Quantisnow.

Quantisnowquantisnow.com

Quantisnow streams SEC filings, FDA approvals, analyst ratings, insider trades, and press releases to retail investors in real time. This insight was curated and delivered from the Quantisnow live feed.

Companies

BCOR
Blucora Inc.
Finance

Recent analyst ratings

Jul 11UpdateCantor Fitzgerald$22.00
Dec 14UpdateJP Morgan$22.00

Related

SEC869d
SEC Form 15-12G filed by Blucora Inc.
SEC869d
SEC Form EFFECT filed by Blucora Inc.
SEC869d
SEC Form EFFECT filed by Blucora Inc.
13D/G875d
SEC Form SC 13G filed by Blucora Inc.
INSIDER877d
Mehlman Marc returned $4,448,860 worth of shares to the company (171,110 units at $26.00) and was granted 80,718 shares, closing all direct ownership in the company (SEC Form 4)
INSIDER877d
Walters Christopher William returned $22,551,854 worth of shares to the company (867,379 units at $26.00) and was granted 513,258 shares, closing all direct ownership in the company (SEC Form 4)
INSIDER877d
Murray Stacy returned $73,996 worth of shares to the company (2,846 units at $26.00), closing all direct ownership in the company (SEC Form 4)
INSIDER877d
Bailey Tabitha returned $488,462 worth of shares to the company (18,787 units at $26.00) and was granted 9,222 shares, closing all direct ownership in the company (SEC Form 4)

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releases Analyst ratings Insider trading FDA SEC RSS feeds

Top lists

Trending By market cap Active companies Analyst upgrades Insider purchases FDA approvals SEC filings Sectors Market reports

Company

About Pricing Publish with us Contact

Legal

Terms of use Privacy policy Cookie policy

© 2026 quantisnow.com · Democratizing insights since 2022